Don't have an account?
NEW ORLEANS – March 3, 2023: GE HealthCare (Nasdaq: GEHC) will present its latest technologies and innovations for use during the critical planning and interventions steps in the cardiology care pathway as the American College of Cardiology (ACC) joins the World Heart Federation to host the ACC.23/WCC conference. The featured technologies and collaborations enable a streamlined cardiology care pathway with integrated solutions which have the potential to reduce the time from diagnosis to treatment, and leverage data and artificial intelligence (AI) to provide actionable insights and, ultimately, help improve health.
“GE HealthCare is focused on building a future in which we are more customer and patient-focused than ever. Our comprehensive portfolio of cardiovascular solutions delivers across the full continuum of care – from the time a patient first starts showing symptoms, to diagnosis and treatment – all the way through intelligent monitoring,” said Eigil Samset, PhD, General Manager, GE HealthCare Cardiology Solutions. “Our technologies provide a complete story of the heart with the goal of improving the workstreams of our customers as well as the quality of life of our patients.”
The prevalence of cardiovascular disease (CVD) has doubled since 1990, and looking ahead, cases of cardiovascular disease are likely to increase substantially due to population growth and aging1. As a result, cardiology procedures are shifting rapidly – requiring a multi-disciplinary approach to optimize workflows, deliver better outcomes, and offer patients the best treatment options. With AI-enabled software to aid in early disease detection, automated workflows that offer a faster exam experience, technologies that support first-line decision making, and innovations in monitoring that increase convenience for patients and aim to reduce cardiac-related hospitalization, GE HealthCare is working towards modernizing and simplifying every step of the customer and patient journey.
GE HealthCare will be exhibiting the following innovations and showcasing the following collaborations at ACC.23/WCC in booth #1925, March 4-6, 2023.
Karin Dalsin
+1 612 219 2855
karin.dalsin@ge.com
About GE HealthCare Technologies Inc.
GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Advanced Imaging Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics segments to help clinicians deliver more personalized, precise patient care. We are a $20.6 billion business with approximately 54,000 colleagues working to create a world where healthcare has no limits.
GE HealthCare is proud to be among 2026 Fortune World’s Most Admired Companies™.
Follow us on LinkedIn, Facebook, Instagram, or visit our website for our latest news and perspectives.